CNTG Projected Dividend Yield

Ord/Centogene NV ( NASDAQ : CNTG )

Centogene is a holding company. Through its subsidiaries, Co. is a commercial-stage company that is focused on rare hereditary diseases. Co. has three reportable segments: pharmaceutical, which provides a variety of solutions to its pharmaceutical partners, including target discovery, early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring; diagnostics, which provides genetic sequencing and diagnostics services to its clients, who are typically physicians, laboratories or hospitals, either directly or through distributors; and COVID-19, which provides COVID-19 testing services to its clients such as COVID-19 antigen testing.

20 YEAR PERFORMANCE RESULTS